Why Novavax Stock Is Soaring Today
Shares of flu vaccine researcher Novavax (NASDAQ: NVAX) shot up 13.7% in early trading Tuesday after a positive analyst note out of Citigroup predicted "strong market opportunities" for the company's new NanoFlu nanoparticle-based flu vaccine. At last report, however, Novavax shares were spotted retracing their gains -- but still up 6.9% as of 11:40 a.m. EDT.
Image source: Getty Images.
Citigroup gave its stamp of approval to Novavax stock, calling NanoFlu "underappreciated by the Street." According to the analyst, Novavax shares that currently trade for just $1.09 apiece could shoot up as high as $1.60 per share within a year.
Source: Fool.com
Novavax Inc. Stock
€15.38
2.130%
Our community is currently low on Novavax Inc. with 7 Buy predictions and 10 Sell predictions.
A potential of -34.97%, resulting from comparing the current price of 15.38 € with the target price of 10 € for Novavax Inc., shows the chance of incurring significant losses.
